Selective Reduction of a Heterotopic Cesarean Scar Pregnancy Complicated by Septic Abortion

por Tymon-Rosario, Joan, Chuang, Meleen
Publicado 2018

Multidrug-Resistant Escherichia coli Resulting in Postpartum Necrotizing Endomyometritis

por Tymon-Rosario, Joan, Chuang, Meleen
Publicado 2019

Robotic radical trachelectomy with an abdominally placed vaginal cerclage for containment of early stage cervical cancer()

por Tymon-Rosario, Joan, Khadraoui, Wafa, Nagarkatti, Nupur, Menderes, Gulden
Publicado 2020

Robotic interval debulking with radical hysterectomy and partial urinary bladder resection for locally advanced carcinosarcoma of the uterus

por Harold, Justin, Murphy, Colleen, Tymon-Rosario, Joan, Menderes, Gulden
Publicado 2022

Sacituzumab govitecan: a promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer

por Webster, Emily M., Zeybek, Burak, Tymon-Rosario, Joan, Santin, Alessandro D.
Publicado 2020

Association between diabetes mellitus and progression free survival in women with ovarian granulosa cell tumors

por Tymon-Rosario, Joan R., Miller, Eirwen M., Gressel, Gregory M., Nevadunsky, Nicole S.
Publicado 2018

Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment

por Tymon-Rosario, Joan, Adjei, Naomi N., Roque, Dana M., Santin, Alessandro D.
Publicado 2021

Streptococcus constellatus Peritonitis and Subsequent Septic Shock following Intrauterine Device Removal

por Tymon-Rosario, Joan, Atrio, Jessica M., Yoon, Hyun Ah, Erlichman, David, Lerner, Veronica
Publicado 2019

Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent

por Webster, Emily M., Tymon-Rosario, Joan, D'Addario, Johanna, Zeybek, Burak, Ratner, Elena S.
Publicado 2020

Blastic variant of plasma cell myeloma mimicking squamous cell carcinoma of the uterine cervix in a super-morbidly obese female

por Tymon-Rosario, Joan R., Shi, Yang, DiVito, Joseph, Aksel, Sarp O., Gressel, Gregory M.
Publicado 2019

An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva

por Li, Jessie Y., Arkfeld, Christopher K., Tymon-Rosario, Joan, Webster, Emily, Schwartz, Peter, Damast, Shari, Menderes, Gulden
Publicado 2021

Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites

por Li, Jessie Y., Mutlu, Levent, Tymon-Rosario, Joan, Khadraoui, Wafa, Nagarkatti, Nupur, Hui, Pei, Buza, Natalia, Lu, Lingeng, Schwartz, Peter, Menderes, Gulden
Publicado 2021

Financial toxicity in patients with gynecologic malignancies: a cross sectional study

por Zeybek, Burak, Webster, Emily, Pogosian, Natalia, Tymon-Rosario, Joan, Balch, Alan, Altwerger, Gary, Clark, Mitchell, Menderes, Gulden, Huang, Gloria, Azodi, Masoud, Ratner, Elena S., Schwartz, Peter E., Santin, Alessandro D., Andikyan, Vaagn
Publicado 2021

Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

por Webster, Emily M., Yadav, Ghanshyam S., Gysler, Stefan, McNamara, Blair, Black, Jonathan, Tymon-Rosario, Joan, Zeybek, Burak, Han, Chanhee, Arkfeld, Christopher K., Andikyan, Vaagn, Menderes, Gulden, Huang, Gloria, Azodi, Masoud, Silasi, Dan-Arin, Santin, Alessandro D., Schwartz, Peter E., Ratner, Elena S., Altwerger, Gary
Publicado 2020

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

por Zeybek, Burak, Manzano, Aranzazu, Bianchi, Anna, Bonazzoli, Elena, Bellone, Stefania, Buza, Natalia, Hui, Pei, Lopez, Salvatore, Perrone, Emanuele, Manara, Paola, Zammataro, Luca, Altwerger, Gary, Han, Chanhee, Tymon-Rosario, Joan, Menderes, Gulden, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro
Publicado 2020

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38...

por Perrone, Emanuele, Lopez, Salvatore, Zeybek, Burak, Bellone, Stefania, Bonazzoli, Elena, Pelligra, Silvia, Zammataro, Luca, Manzano, Aranzazu, Manara, Paola, Bianchi, Anna, Buza, Natalia, Tymon-Rosario, Joan, Altwerger, Gary, Han, Chanhee, Menderes, Gulden, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Hui, Pei, Schwartz, Peter E., Scambia, Giovanni, Santin, Alessandro D.
Publicado 2020

Sacituzumab govitecan, an antibody‐drug conjugate targeting trophoblast cell‐surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas i...

por Perrone, Emanuele, Manara, Paola, Lopez, Salvatore, Bellone, Stefania, Bonazzoli, Elena, Manzano, Aranzazu, Zammataro, Luca, Bianchi, Anna, Zeybek, Burak, Buza, Natalia, Tymon‐Rosario, Joan, Altwerger, Gary, Han, Chanhee, Menderes, Gulden, Huang, Gloria S., Ratner, Elena, Silasi, Dan‐Arin, Azodi, Masoud, Hui, Pei, Schwartz, Peter E., Scambia, Giovanni, Santin, Alessandro D.
Publicado 2020

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

por Roque, Dana M., Siegel, Eric R., Buza, Natalia, Bellone, Stefania, Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Rao, Gautam G., Reader, Jocelyn C., Hui, Pei, Tymon-Rosario, Joan R., Harold, Justin, Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Ratner, Elena, Santin, Alessandro D.
Publicado 2022

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas

por Lopez, Salvatore, Perrone, Emanuele, Bellone, Stefania, Bonazzoli, Elena, Zeybek, Burak, Han, Chanhee, Tymon-Rosario, Joan, Altwerger, Gary, Menderes, Gulden, Bianchi, Anna, Zammataro, Luca, Manzano, Aranzazu, Manara, Paola, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., Raspagliesi, Francesco, Angioli, Roberto, Buza, Natalia, Hui, Pei, Bond, Heather M., Santin, Alessandro D.
Publicado 2020